What does the Affordable Care Act mean for Drug Manufacturers?

This post was authored by the Medicaid Drug Rebates Program Summit Producer, Heather King. You can follow her on Twitter at @HeatherIIR.

Did you breathe a sigh of relief on June 28 when the Supreme Court left PPACA mostly as it originated?

Do you think that decision means things are status quo? After all, there’s no Final Rule for the AMP Guidance yet and PPACA was (mostly) upheld, so why take time out of your busy schedule to attend an event like ours?

The answer is simple: There is no such thing as the status quo when it comes to public sector reimbursement programs for the pharmaceutical industry.

Anyone who has been working in this space for long enough knows that little technical, policy or operations changes can make a huge difference in doing business. And not only do we have these “little” changes, but the one provision in PPACA that SCOTUS did amend will have a huge impact on how you do business in the coming years – States’ participation in the expansion of Medicaid is now OPTIONAL.

We work in Medicaid Drug Rebates. Every person in every state (and DC) that uses Medicaid affects our prices, our forecasting, and our bottom lines. How can we anticipate an expansion and all its implications when we don’t even know which states will choose to expand the program? The figure can be upwards of 17 million additional Americans that we have to provide products for. This uncertainty could be crippling to our organizations.

At the 17th Annual Medicaid Drug Rebate Program Summit, we pride ourselves on bringing a clarity to our audience unsurpassed in the industry from every side of the MDRP Space.

• - If you have policy, technical or operational questions about a government program, we have CMS, OPA, Part D and OIG representatives on hand to answer them.
• - If you have questions on interpretation of rules, or best practices for dealing with all the paperwork involved in rebating, or accruing and accounting for liability, we have the leading legal and financial consulting firms, and service providers in the business.
• - If you have questions on what your peers are doing and what’s working and what’s not, we have more senior branded and generic manufacturer executives on hand to give you practical information than any other event in the country.
• - And if you want to know what the States are doing, and how they see the next few years playing out in their state regarding the expansion, we have more State Medicaid Rebate specialists than any other event, and we are the ONLY event that assists with dispute resolution.

Find out more about this year’s program by downloading the agenda.

As a reader of this blog, you receive an exclusive discount of 25% off of the standard rate when you register to join us this September 10-12, 2012 in Chicago, IL. Simply use priority code XP1758BLOG. Do you have any questions about the event? Feel free to email Jennifer Pereira.